Академический Документы
Профессиональный Документы
Культура Документы
Enterocutaneous Fistula
(ECF)
JA N UA RY 5 , 2 0 1 5
JE N I F ER L A
K E E N E STATE COL L EG E DI E TETI C I N T ERNSHIP 2 0 1 4 - 2015
Outline
Catholic Medical Center
Enterocutaneous Fistulas
Case Study
TPN Review
Non-profit
Location: West Side area of
Manchester,
New Hampshire
ECF Background
Complex patients w/ considerable
morbidity and mortality
Major complications:
ECF Background
Requires multidisciplinary approach
Spontaneous closures is variable depending on
Etiology
Nutritional status
Output of Fistula
ECF Classification
Anatomical Classification: Internal or External
Internal: named after the structures it communicates with
External: gastric, duodenal, jejunal, ileal, or fecal
ECF - Etiology
Post-operative complication (~75%)
ECF - Trauma
Surgical
Injury/Accidents
Spontaneous causes
Malignancy, radiation, intra-abdominal sepsis, IBD
Inadvertent enterotomy
Inadvertent small bowel injury
ECF Pathophysiology
Formed by abnormal connection between GI tract and skin due to
post-op or trauma
Contents of the stomach and/or intestine leak through the skin
Fever
Localized erythema
Increased intra-abdominal pressure
Passage of mucus and blood
Electrolyte imbalance
Malnutrition
Not Favorable
Organ
Oropharyngeal, Esophageal,
Duodenal stump, Jejunal, Colonic
Etiology
Post-op, Appendicitis,
Diverticulitis
Malignancy, IBD
Output
Nutritional State
Well nourished
Malnourished
State of Bowel
Fistula Characteristic
Tract > 2 cm
Bowel wall defect < 1 cm2
Tract < 2 cm
Bowel defect > 1 cm2
ECF Labs
Total leukocyte count increased levels + sepsis = leukocytosis
ECF Management
Multidisciplinary approach
Conservative Therapy: SSNAP
Stabilization
Sepsis control and Skin/wound management
Nutrition
Anatomy
Plan
Surgery
Focuses on
Rehydration
Antibiotics
Correction of anemia
Electrolyte repletion
Drainage of abscess
Nutritional support
Skin/wound healing/protection
Control of sepsis
Bogota Bag
VAC
Enteral vs TPN
Enteral preferred
Avoids line-related complications (sepsis, thrombosis,
pneumothorax)
Trophic effect on bowel mucosa
Supports immunological, barrier, and hormonal functions of the
gut
High calorie, protein supplements, electrolyte mix
Calorie REQ
Protein REQ
Fluid REQ
Low Output
High Output
30 35kcal/kg/d
40 45kcal/kg/d
1 1.5gm/kg/d
1.5 2.5gm/d
1L/d of electrolyte
solution + <
500ml/d of low
sodium fluid of
choice
Primary Goals
Time of Course
7-10d
5.) Healing
Primary Goal
Determine likelihood of
spontaneous closure and
course of therapy
Closure of fistula,
Reestablish GI continuity,
Secure closure of
abdomen
Ensure adequate
nutrition, Transition to
PO intake
Time of Course
4-6 weeks
February beginning September 2014 followed low fiber, lactose free diet
September November 2014 TPN; was being introduced to full liquid diet
causing increased output, fever, weakness, and diarrhea leading to her most
recent admission
Medications:
Vit B Complex
Iron
Lactobacillus Acidophilus
PPI
Zosyn
IVF
Lopressor
Lovenox
63.5kg (139#)
76.6kg (168.7#)
Ht
BMI
% UBW
5 6
21.9
83%
% IBW
Wt Change
106%
- 13kg (- 30#) x 10 months
75
Wt (kg)
70
65
60
55
50
January
February
May
Time Frame
Wt (kg)
September
November
M.C.
Normal Range
Hemoglobin
8.5 g/dL
Hematocrit
26.5 %
35.0 48.0 %
Sodium
134 mEq/L
Potassium
4.1 mEq/L
Chloride
102 mEq/L
92 105 mEq/L
Calcium
7.7 mg/dL
9 11mg/dL
Magnesium
1.6 mEq/L
Phosphorous
2.0 mg/dL
BUN
37 mg/dL
6 26mg/dL
Creatinine
0.9 mg/dL
Glucose
91 mg/dL
65 99 mg/dL
Total Protein
6.0 g/dL
6.4 8.2g/dL
Albumin
1.9 mg/dL
Pre-Albumin
4.8 mg/dL
Albumin g/dL
2.5
1.5
1
May
September
Time
Albumin g/dL
November
Take the total CHO calories and divide by .70 to get grams of CHO
Take grams CHO divide by 3.4 kcal/gm to get ml of 70% dextrose
solution
220 (635x.15)4-(330x2) = 1159kcal
1159kcal/.70 = 1655.7gm/3.4 = 487ml 485ml
D70 485ml
AA15 635ml
L20 330 ml
Sterile H2O qs for total volume 1950ml, DR = 80ml x 24hr
Yields 2195kcal, 95.25g protein
Nutrition Diagnosis:
Malnutrition r/t altered GI function AEB 17% unintentional wt loss in the past 10
months, generalized muscle wasting, pre-albumin level of 4.8 mg/dL and TPN order
not meeting adequate energy-protein needs.
Altered nutrition-related laboratory values r/t less than optimal parenteral nutrition
infusion AEB pre-albumin 4.8 mg/dL, albumin 1.9mg/dL, and unintentional 17% wt
loss x 10 months.
References
Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am. Oct
1996;76(5):1009-18.
Draus JM Jr, Huss SA, Harty NJ, et al. Enterocutaneous fistula: are treatments improving?. Surgery. Oct
2006;140(4):570-6; discussion 576-8
Ham M, Horton K, Kaunitz J. Fistuloclysis: case report and literature review. Nutr Clin Pract. Oct 2007;22(5):553-7.
Pritts, T., Fischer, D., Discher, J. (2001.) Surgical Treatment: Evidence-Based and Problem Orientated. Postoperative
Enterocutaneous Fistula. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK6914/
Schecter WP. Management of enterocutaneous fistulas. Surg Clin North Am. Jun 2011;91(3):481-91
Vikram, K. (2014). Enterocutaneous Fistula. Retrieved from http://emedicine.medscape.com/article/1372132overview#aw2aab6c14
Willcutts, K. (2010). Practical Gastroenterology: Nutrition Issues in Gastroenterology. The Art of Fistuloclysis:
Nutrition Management of Enterocutaneous Fistula. (87). Retrieved from
http://www.medicine.virginia.edu/clinical/departments/medicine/divisions/digestive-health/nutrition-supportteam/nutrition-articles/WillcuttsArticle.pdf